Sarcopenia in patients with rheumatic musculoskeletal diseases.

Hironari HanaokaJun KikuchiKazuoto HiramotoMitsuhiro AkiyamaShutaro SaitoYasushi KondoYuko Kaneko

Published in: International journal of rheumatic diseases (2023)

One-month hospitalization with high-dose glucocorticoid therapy is associated with sarcopenia progression in patients with RMDs. An early decrease in body weight can be used to predict muscle volume loss.

Keyphrases

body weight
skeletal muscle
high dose
low dose
community dwelling
rheumatoid arthritis
stem cell transplantation
stem cells
mesenchymal stem cells
bone marrow